Long-term results of intratumorous bleomycin-A5 injection for head and neck lymphangioma
-
Add time:07/23/2019 Source:sciencedirect.com
From June 1987 to June 1995, 200 patients with various types of head and neck lymphangioma were treated by intratumorous injection of bleomycin-A5. All 200 cases were followed from 2 to 10 years; 95 cases were followed for more than 5 years. The effective rate was 97%, and the curative rate was 86.5%. No pulmofibrosis or other serious complications were found. The relationships between the curative effect and tumor type, size, and side effects of bleomycin are discussed.
We also recommend Trading Suppliers and Manufacturers of Bleomycin A5 (cas 11116-32-8). Pls Click Website Link as below: cas 11116-32-8 suppliers
Prev:A clinical study of ultrasound-guided intralesional injection of Bleomycin A5 (cas 11116-32-8) on venous malformation in cervical-facial region in China
Next:Synthesis of crosslinked starch-graft-polyacrylamide-co-sodium xanthate and its performances in wastewater treatment) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- A clinical study of ultrasound-guided intralesional injection of Bleomycin A5 (cas 11116-32-8) on venous malformation in cervical-facial region in China07/22/2019
- Electrophoresis mobility shift assay and biosensor used in studying the interaction between Bleomycin A5 (cas 11116-32-8) and DNA07/20/2019
- Bleomycin A5 (cas 11116-32-8) plus dexamethasone for control of growth in infantile parotid hemangiomas07/21/2019
- Bleomycin A5 (cas 11116-32-8) sclerotherapy for cervicofacial lymphatic malformations07/19/2019
- How to use Bleomycin A5 (cas 11116-32-8) for infantile maxillofacial haemangiomas: Clinical evaluation of 82 consecutive cases07/18/2019
-
Health and Chemical more >